SitePad® System

Find Information Faster:

I'm in ... (choose one)
StudyWorks Login
Preferred by Clinicians

Preferred by Clinicians

Easy to Capture Patient Data at the Site

TOP THERAPEUTIC AREAS USING THE SITEPAD®

Each Sitepad supports up to 500 Patients

Each Sitepad supports up to 500 Patients

SitePad® System

The SitePad is a mobile eCOA data collection tablet used to capture multiple patient-reported and clinician assessments at the site. The SitePad System raises the quality of site-based real-time data capture for ePRO/eCOA patients and study coordinators.  PHT worked with study coordinators to design the SitePad System’s mobile eSource device with a large touch screen and user-friendly interface. Each device supports 500 patients.

  • Study Design

    The SitePad System uses protocol-specific branching, logical automatic calculations, and reliable high-speed data transmissions. You can collect:

    • Clinical Outcome Assessments (COAs)
    • Clinician Reported Outcomes (ClinRO)
    • Patient ePROs
    • Site surveys and questionnaires

  • Increased Efficiencies for Sponsors and CROs

  • End-to-End Trial Support

    • Comprehensive Training
    • Seamless mid-study changes
    • Integretion with smartphone, Internet and hand held data collection
    • 24/7 Support

  • Why Choose PHT ePRO Over Paper?

    • Faster time-to-database lock
    • Accurate verifiable timestamps
    • High-speed eSource data transmission
    • Full integration with PHT StudyWorks® online reporting portal

  • Attributable, Time-Stamped Data for Rapid Analysis

    • Restricted time response window
    • Provides branching logic and protocol-specific workflows
    • On-device calculations, dosing calculations and prescription capabilities
    • 21 CFR 312.62. compliant
    • Patented handwritten signatures and private access codes

  • eCOA System Datasheet

Capture Unfiltered Data

End the cycle of incomplete and unreliable patient questionnaire data. The SitePad System delivers unbiased PROs directly from patients at the site.